The orphan nuclear receptor NR4A2 is part of a p53-microRNA-34 network

被引:31
作者
Beard, Jordan A. [1 ,2 ]
Tenga, Alexa [1 ,2 ]
Hills, Justin [1 ]
Hoyer, Jessica D. [1 ,2 ]
Cherian, Milu T. [1 ]
Wang, Yong-Dong [3 ]
Chen, Taosheng [1 ,2 ]
机构
[1] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] Univ Tennessee, Ctr Hlth Sci, Integrated Biomed Sci Program, Memphis, TN 38163 USA
[3] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
基金
美国国家卫生研究院;
关键词
CANCER-CELLS; CONFERS CHEMORESISTANCE; MIR-34; FAMILY; P53; EXPRESSION; NURR1; SURVIVAL; PREDICTS; NEUROBLASTOMA; MODULATION;
D O I
10.1038/srep25108
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nuclear receptor subfamily 4 group A member 2 (NR4A2) is an orphan nuclear receptor that is over-expressed in cancer and promotes cell proliferation, migration, transformation, and chemoresistance. Increased expression and function of NR4A2 have been attributed to various signaling pathways, but little is known about microRNA (miRNA) regulation of NR4A2 in cancer. To investigate the posttranscriptional regulation of NR4A2, we used a 3' untranslated region (UTR) reporter screen and identified miR-34 as a putative regulator of NR4A2. By using computer predictions, we identified and confirmed an miRNA recognition element in the 3' UTR of NR4A2 that was responsible for miR-34-mediated suppression. We next demonstrated that overexpression of exogenous miR-34 or activation of the p53 pathway, which regulates endogenous miR-34 expression, decreased NR4A2 expression. Consistent with previous reports, overexpression of NR4A2 blocked the induction of p53 target genes, including mir-34a. This was a phenotypic effect, as NR4A2 overexpression could rescue cells from p53-induced inhibition of proliferation. In summary, our results are the first characterization of a cancer-related miRNA capable of regulating NR4A2 and suggest a network and possible feedback mechanism involving p53, miR-34, and NR4A2.
引用
收藏
页数:14
相关论文
共 58 条
  • [1] Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells
    Akao, Yukihiro
    Noguchi, Shunsuke
    Iio, Akio
    Kojima, Keitaro
    Takagi, Takeshi
    Naoe, Tomoki
    [J]. CANCER LETTERS, 2011, 300 (02) : 197 - 204
  • [2] Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120
  • [3] MicroRNAs: Target Recognition and Regulatory Functions
    Bartel, David P.
    [J]. CELL, 2009, 136 (02) : 215 - 233
  • [4] The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer
    Beard, Jordan A.
    Tenga, Alexa
    Chen, Taosheng
    [J]. CELLULAR SIGNALLING, 2015, 27 (02) : 257 - 266
  • [5] Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
    Chang, Tsung-Cheng
    Wentzel, Erik A.
    Kent, Oliver A.
    Ramachandran, Kalyani
    Mullendore, Michael
    Lee, Kwang Hyuck
    Feldmann, Georg
    Yamakuchi, Munekazu
    Ferlito, Marcella
    Lowenstein, Charles J.
    Arking, Dan E.
    Beer, Michael A.
    Maitra, Anirban
    Mendell, Joshua T.
    [J]. MOLECULAR CELL, 2007, 26 (05) : 745 - 752
  • [6] Nuclear receptor drug discovery
    Chen, Taosheng
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (04) : 418 - 426
  • [7] A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene
    Cole, Kristina A.
    Attiyeh, Edward F.
    Mosse, Yael P.
    Laquaglia, Michael J.
    Diskin, Sharon J.
    Brodeur, Garrett M.
    Maris, John M.
    [J]. MOLECULAR CANCER RESEARCH, 2008, 6 (05) : 735 - 742
  • [8] Intact p53-Dependent Responses in miR-34-Deficient Mice
    Concepcion, Carla P.
    Han, Yoon-Chi
    Mu, Ping
    Bonetti, Ciro
    Yao, Evelyn
    D'Andrea, Aleco
    Vidigal, Joana A.
    Maughan, William P.
    Ogrodowski, Paul
    Ventura, Andrea
    [J]. PLOS GENETICS, 2012, 8 (07):
  • [9] Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
    Corney, David C.
    Hwang, Chang-Il
    Matoso, Andres
    Vogt, Markus
    Flesken-Nikitin, Andrea
    Godwin, Andrew K.
    Kamat, Aparna A.
    Sood, Anil K.
    Ellenson, Lora H.
    Hermeking, Heiko
    Nikitin, Alexander Yu.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (04) : 1119 - 1128
  • [10] Reduced Levels of miR-34a in Neuroblastoma Are Not Caused by Mutations in the TP53 Binding Site
    Feinberg-Gorenshtein, Galina
    Avigad, Smadar
    Jeison, Marta
    Halevy-Berco, Gili
    Mardoukh, Jacques
    Luria, Drorit
    Ash, Shifra
    Steinberg, Ran
    Weizman, Avraham
    Yaniv, Isaac
    [J]. GENES CHROMOSOMES & CANCER, 2009, 48 (07) : 539 - 543